IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

A Comprehensive Review of Generative AI Applications in Drug Safety: Predicting Interactions and Adverse Effects

A Comprehensive Review of Generative AI Applications in Drug Safety: Predicting Interactions and Adverse Effects
View Sample PDF
Author(s): R. S. M. Lakshmi Patibandla (Koneru Lakshmaiah Education Foundation, India & Singapore Institute of Technology, Singapore), Sivaneasan Balakrishnan (Singapore Institute of Technology, Singapore), Mohammed Ali Hussain (Sreenidhi Institute of Science and Technology, India)and Prasun Chakrabarti (Sir Padampat Singhania University, India)
Copyright: 2027
Pages: 21
Source title: Encyclopedia of Modern Artificial Intelligence
Source Author(s)/Editor(s): Mehdi Khosrow-Pour, D.B.A. (Founding Editor-in-Chief, Information Resources Management Journal (IRMJ), USA)
DOI: 10.4018/407367

Purchase


Abstract

The forecast of drug-drug interactions (DDIs) and adverse drug reactions (ADRs) is something that has a direct relationship with the safety of the patient. Boom in polypharmacy is an additional justification for the above statement. The objective of the traditional models, such as clinical trials and post-market surveillance, is to identify the DDIs and ADRs. However, these models are limited mainly in the diversity, granularity, and timeliness of the data that they rely on. Generative AI has come on the plate as a possible option as it is capable of creating new drug combinations and thus predicting the likely perils by applying machine learning methodologies. This survey on the continued developments related to the use of generative AI in both DDI and ADR will cover GANs, VAEs, and specifically, transformers. The authors discuss the ethical and legal implications of using these models in clinical practice in addition to outlining data sources and methodological difficulties. Future directions to enhance generative AI in pharmacovigilance are also highlighted.

Related Content

Frederic Andres. © 2027. 14 pages.
Kalsoom Safdar, Khairul Najmy Abdul Rani, Mohd Aminudin Jamlos, Siti Julia Rosli, Muhammad Usman Younus, Zanab Safdar. © 2027. 27 pages.
Bani Adam, Binastya Anggara Sekti, Muhammad Adi Zacky Zahran. © 2027. 24 pages.
Swetha Margaret T. A., Renuka Devi D.. © 2027. 31 pages.
Maurice Saluschke, Michael Schulz. © 2027. 30 pages.
Mirjam Sepesy Maučec, Gregor Donaj. © 2027. 16 pages.
Jorge A. Ruiz-Vanoye, Ocotlan Diaz-Parra, Ricardo A. Barrera-Cámara, Alejandro Fuentes-Penna, Francisco R. Trejo-Macotela, Jaime Aguilar-Ortiz, Eric Simancas-Acevedo. © 2027. 21 pages.
Body Bottom